R
Rene Gerolami
Publications - 1
Citations - 232
Rene Gerolami is an academic researcher. The author has contributed to research in topics: Hepatitis B & Lamivudine. The author has an hindex of 1, co-authored 1 publications receiving 229 citations.
Papers
More filters
Journal ArticleDOI
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
Eugene R. Schiff,Cjing Lung Lai,Stephanos J. Hadziyannis,Peter Nuehaus,Norah A. Terrault,Massimo Colombo,Hans L. Tillmann,Didler Samuel,Stefan Zuezem,Jean Pierre Villenueve,Sarah Arteburn,Katyna Borroto-Esoda,Carol L. Brosgart,Steven Chuck,Ahmad Obaid Shakil,Jhon Fung,Alfredo Alberti,Anna Lok,Antonio Picciotto,Francesco Torre,Caroline A. Riely,Christian Trepo,Thierry Bizollon,Danielle Bottaa-Fridlund,Rene Gerolami,David D. Douglas,Dinesh Ranjan,D Faust,Joerg Trojan,Edward Gane,Erica Villa,Modentina Boarino,Etienne Sokal,Peter Stärkel,Ferruccio Bonino,Brunetto Maurizio,Fred Gordon,Jo Anne Pratt,Frieder Berr,Ingolf Schiefke,Geoff McCaughan,Simone I. Strasser,Geoffrey Dusheiko,G.-P. Pageaux,Dominique Larrey,Giuseppe Pastore,Teresa Santantonio,Graeme J.M. Alexander,Tracy Woodall,Han Van Vlierberghe,Isabelle Colle,Hugh Harley,Jean Guggenheim,Aline Myx-Staccini,Jean Michel Metreau,Philippe Mavier,John M. Vierling,Tram Tran,Nigel Girgrah,Lisa M. Nyberg,Man-Fung Yuen,Mang Ma,Manuel Delgado Balnco,Manuela Merli,Paola Tanzilli,Mario Angelico,Daniele Di Paolo,Mario Rizzetto,Alfredo Marzano,Pietro Lampertico,Martín Prieto,Marina Berenguer,Martina Felder,Martina Sterneck,Marc Willems,Michael Charlton,Timothy J. Gunneson,Michael Ritter,Michael Voight,Judy Swift,Mitchell L. Shiffman,Nicholas Tassopoulos,Isidoros Klissas,Nikolai Naourmov,Patrick Chamouard,Patrick Marcellin,François Durand,Peter W Angus,Connelly Nathan,Pierluigi Toniutto,Elisabetta Fumo,Pietro Andreone,Carmela Cursaro,Rafael Bárcena,Fernando Garcia Hoz,Reinhard Zachoval,Maria Christina,Robert A. de Man,Herold J. Metselaar +98 more
TL;DR: Adefovir dipivoxil is effective and safe in wait‐listed or post–liver transplantation chronic hepatitis B patients with lamivudine‐resistant HBV and prevents graft reinfection with or without HBIg.